Microbial degradation of the phytosterol side-chain to 24-oxo products
摘要:
A mutant of the potent sterol degrader Mycobacterium fortuitum (ATCC 6842) has been isolated which is defective in its ability to degrade both the steroid nucleus and sterol side-chains that are branched at the 24-position. Bioconversions of phytosterol mixtures by this mutant resulted in the accumulation of the novel 24-oxo intermediates 9-hydroxy-27-nor-4-cholestene-3,24-dione (II) and 9-hydroxy-26,27-dinor-4-cholestene-3,24-dione (III). Under the same conditions, cholesterol is degraded mainly to 9-hydroxy-4-androstene-3,17-dione (I) by this organism.
Microbial degradation of the phytosterol side-chain to 24-oxo products
摘要:
A mutant of the potent sterol degrader Mycobacterium fortuitum (ATCC 6842) has been isolated which is defective in its ability to degrade both the steroid nucleus and sterol side-chains that are branched at the 24-position. Bioconversions of phytosterol mixtures by this mutant resulted in the accumulation of the novel 24-oxo intermediates 9-hydroxy-27-nor-4-cholestene-3,24-dione (II) and 9-hydroxy-26,27-dinor-4-cholestene-3,24-dione (III). Under the same conditions, cholesterol is degraded mainly to 9-hydroxy-4-androstene-3,17-dione (I) by this organism.
We describe the structure and stereochemistry of some new 26-oxygenated steroid derivatives obtained by microbial transformation of sitosterol.
NOVEL 9$g(a)-HYDROXY-3-OXO-4,24(25)-STIGMASTADIEN-26-OIC ACID DERIVATIVES, A PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
申请人:RICHTER GEDEON VEGYESZETI GYAR R.T.
公开号:EP0424504B1
公开(公告)日:1994-04-13
US5112815A
申请人:——
公开号:US5112815A
公开(公告)日:1992-05-12
[EN] NOVEL 9 alpha -HYDROXY-3-OXO-4,24(25)-STIGMASTADIEN-26-OIC ACID DERIVATIVES, A PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
申请人:RICHTER GEDEON VEGYÉSZETI GYÁR R.T.
公开号:WO1990013559A1
公开(公告)日:1990-11-15
(EN) The invention relates to novel 9$g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives of general formula (I), wherein M stands for hydrogen, C1-4 alkyl or a pharmaceutically acceptable cation. Further the invention relates to a process for preparing these compounds. The new compounds of general formula (I) exert anti-hypercholesteremic effect.(FR) L'invention se rapporte à de nouveaux dérivés d'acide 9$g(a)-hydroxy-3-oxo-4,24(25)-stigmastadiène-26-oïque, représentés par la formule générale (I), où M représente l'hydrogène, un alkyle de 1 à 4 atomes de carbone ou un cation pharmaceutiquement acceptable. L'invention se rapporte en outre à un procédé de préparation de ces composés. Ces nouveaux composés représentés par la formule générale (I) ont une action anti-hypercholestérolémie.